Healthbridge Announces Appointment of New Director.Business Editors/Health/Medical Writers VANCOUVER, British Columbia--(BUSINESS WIRE)--April 19, 2004 Healthbridge Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). : HHBR) (Berlin Stock Exchange: HBZ HBZ HochschulBibliotheksZentrum HBZ Hrvatska Bratska Zajednica (Croatian Fraternal Union, USA; since 1894) ) today announced the appointment of James Ladner to the board of directors of Healthbridge's wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. Healthbridge (Deutschland) AG. Ladner is an international financial consultant who resides in Zurich, Switzerland. Ladner began his professional career at Handelsbank in Zurich which later became a subsidiary of the National Westminster Bank in Switzerland where he was employed for 28 years. During his tenure at the National Westminster Bank, Ladner rose to the position of executive vice president. After leaving the bank, Ladner co-founded Rauscher Pierce & Co. International ("R P & C"), an investment banking boutique with offices in New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of and London. Ladner acted as a managing director of R P & C until 2002. Over time Ladner has served on the board of directors of several companies, most of which have been financial institutions. He acted as the non-executive chairman of the board of Bank of Austria (Switzerland), director of The Royal Bank of Scotland
The Royal Bank of Scotland Plc (Scottish Gaelic: Banca Rìoghail na h-Alba AG, the Japanese Asahi Bank (Switzerland) and Interallianz Bank. Ladner currently serves on the board of directors of F. van Lanschot Bankiers (Switzerland), Energy Capital Investment Co. Plc and Strata Gold Corp. Ladner graduated in economics and business administration from the University of St. Gallen The University of St. Gallen (in German: Universität St. Gallen) is both a research university, a vocational university and a business school based in St. Gallen, Switzerland. in Switzerland. Healthbridge is the exclusive owner of the Valides(R) System, a progressive technology designed for infectious medical waste sterilization and disposal. The Valides(R) System was developed in Germany to combat the global environmental problems associated with the sterilization and disposal of infectious medical wastes generated by hospitals, laboratories, dental offices, clinics, blood banks and other healthcare sector facilities. Growing concern over the potential effects of infectious waste disposal on our environment has caused regulators worldwide to impose increasingly rigid air quality, health and safety standards for incinerator or landfill disposal. Tougher standards have caused a prohibitive escalation of the costs associated with the disposal of infectious waste. Medical facilities around the world are in dire need of an effective solution that balances legitimate concerns over the environment with the cost-effective disposal of medical waste. Healthbridge (Deutschland) AG recently announced its first sale of Valides(R) System to the newly constructed London Hospital, located in Kuwait City, with delivery of this unit scheduled for May 2004. Healthbridge is to provide consulting support to the staff of the London Hospital to ensure proper training in the efficient use of the Valides(R) System. Once the initial equipment is fully operational, GBD GBD Global Burden of Disease GBD Glass Break Detector (security systems) GBD Golden, Brown and Delicious GBD Ground Branch Director GBD Global Burst Detector GBD Generation Breakdown GBD Geometric Data Base General Trading Co., a local Kuwaiti distributor, has indicated a need for five additional units to meet medical waste sterilization and disposal requirements at other locations. Healthbridge anticipates that the appointment of Ladner to the board of directors of Healthbridge (Deutschland) AG will be beneficial to the company in its efforts to secure sufficient capital to expand the introduction of the Valides(R) System on a worldwide basis. A number of statements contained in this press release are forward-looking statements that are made pursuant to the safe harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. provisions of the Private Securities Litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute. When a person begins a civil lawsuit, the person enters into a process called litigation. Act of 1995. These forward-looking statements involve a number of risks and uncertainties, including timely development, and market acceptance of products and technologies, competitive market conditions, successful integration of acquisitions and the ability to secure additional sources of financing. The actual results that Healthbridge may achieve could differ materially from any forward-looking statements due to such risks and uncertainties. Healthbridge encourages the public to read the information provided here in conjunction with its most recent filings on Form 10KSB KSB Kogod School of Business (American University) KSB Kelley School of Business (Indiana University) KSB Kantonsschule Am Brühl St. and Form 10QSB QSB Fading QSB Qualified Small Business (IRS category) QSB Queen Street Backpackers (Auckland, New Zealand) QSB Quality System Basics QSB Qualified Supplemental Benefit QSB Quantum Singleton Bound . Healthbridge Inc. public filings may be viewed at www.sec.gov. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion